These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 18819300)

  • 21. Cardiac medication in the perioperative period.
    Wallner T; Preis C; Mayer N
    Acta Anaesthesiol Scand Suppl; 1997; 111():22-8. PubMed ID: 9420942
    [No Abstract]   [Full Text] [Related]  

  • 22. [Coronary heart disease and dyslipdemia - dosing recommendations at beginning and end of treatment].
    Blessing E
    Ther Umsch; 2008 Oct; 65(10):593-7. PubMed ID: 18821518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular disease medications after renal transplantation: results from the Patient Outcomes in Renal Transplantation study.
    Pilmore HL; Skeans MA; Snyder JJ; Israni AK; Kasiske BL
    Transplantation; 2011 Mar; 91(5):542-51. PubMed ID: 21301401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacologic prevention of cardiovascular diseases--2005].
    Kancz S
    Orv Hetil; 2005 May; 146(20 Suppl 2):1122-31. PubMed ID: 15945241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence-based use of medications in patients with coronary artery disease in a rural Australian community.
    Granmyr J; Ball P; Curran S; Wang L
    Aust J Rural Health; 2007 Aug; 15(4):241-6. PubMed ID: 17617087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New possibilities in the pharmacologic prevention of age-related macular degeneration].
    Fischer T
    Orv Hetil; 2008 Jan; 149(3):121-7. PubMed ID: 18194920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular pharmacotherapy in patients with Marfan syndrome.
    Yetman AT
    Am J Cardiovasc Drugs; 2007; 7(2):117-26. PubMed ID: 17503882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Progress in cardiovascular pharmacology].
    Zhu JR
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Dec; 21(6):358-60. PubMed ID: 7913889
    [No Abstract]   [Full Text] [Related]  

  • 29. [The role of genetic polymorphisms of cytochrome P450 in drug metabolism used in the treatment of cardiovascular diseases].
    Wojtczak A; Skretkowicz J
    Kardiol Pol; 2009 Sep; 67(9):1011-4. PubMed ID: 19838960
    [No Abstract]   [Full Text] [Related]  

  • 30. [The drug prevention of coronary heart disease].
    Willich SN
    Dtsch Med Wochenschr; 1993 Feb; 118(8):270-6. PubMed ID: 8095235
    [No Abstract]   [Full Text] [Related]  

  • 31. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heart failure.
    McKelvie R
    Clin Evid; 2002 Dec; (8):60-81. PubMed ID: 12603873
    [No Abstract]   [Full Text] [Related]  

  • 33. Drugs used in heart disease. 2. Pharmacology.
    Shulman R; Davies R; Landowski R
    Nurs Times; 2002 May 7-13; 98(19):41-4. PubMed ID: 12035397
    [No Abstract]   [Full Text] [Related]  

  • 34. Heart failure.
    McKelvie R
    Clin Evid; 2002 Jun; (7):57-78. PubMed ID: 12230638
    [No Abstract]   [Full Text] [Related]  

  • 35. A new horizon in primary prevention of cardiovascular disease, can we prevent heart attack by "heart polypill"?
    Rastegarpanah M; Malekzadeh F; Thomas GN; Mohagheghi A; Cheng KK; Marshall T
    Arch Iran Med; 2008 May; 11(3):306-13. PubMed ID: 18426322
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuropsychiatric consequences of cardiovascular medications.
    Huffman JC; Stern TA
    Dialogues Clin Neurosci; 2007; 9(1):29-45. PubMed ID: 17506224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Process of care for carotid endarterectomy: perioperative medical management.
    Stoner MC; Defreitas DJ
    J Vasc Surg; 2010 Jul; 52(1):223-31. PubMed ID: 20304588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-reactive protein (CRP)-lowering agents.
    Prasad K
    Cardiovasc Drug Rev; 2006; 24(1):33-50. PubMed ID: 16939632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controversies in antiplatelet therapy for patients with cardiovascular disease.
    Bates ER; Lau WC
    Circulation; 2005 May; 111(17):e267-71. PubMed ID: 15867186
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug treatment following an infarction].
    Lasserre B; Périat M
    Rev Med Suisse Romande; 1994 Aug; 114(8):677-81. PubMed ID: 7939090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.